In her latest op-ed for @weforum.org, our CEO, @jayiyer.bsky.social, explores how #AI could help bridge #healthcare gaps worldwide & what must happen to ensure it benefits everyone, not just the well-resourced. Read more➡️ accesstomedicinefoundation.org/in-the-media... #Access2Meds #HealthEquity
This week, our CEO @jayiyer.bsky.social is attending the #AMR 2026 Summit in Sydney, where she'll join a panel on investor action & AMR & take part in a keynote session on how environmental requirements affect smaller antibiotic manufacturers. Learn more➡️ tinyurl.com/38rdtw7a #Access2Meds
#HiringNow 📣 We’re looking for a Researcher to support analytical work across our programmes, assessing how #healthcare companies address #Access2Meds & turning data into insights that inform our work. Learn more & apply now➡️ accesstomedicinefoundation.org/researcher #hiring #vacancy #research
#NTDs affect 1B+ people worldwide, mostly in underserved communities. Gaps in #Access2Meds mean many are still left behind. #WorldNTDDay is a moment to reflect on what’s needed to close these gaps, including stronger action from the industry. Learn more➡️ tinyurl.com/4r4kf4s9 #BeatNTDs #GlobalHealth
This week, our CEO @jayiyer.bsky.social is attending #JPMHC26 in San Francisco, joining #pharma leaders, #investors & policymakers to discuss strategic priorities & investment trends shaping #healthcare worldwide. Learn more➡️ accesstomedicinefoundation.org/event/jayasr... #Access2Meds #GlobalHealth
Clinical research remains concentrated in only a few places, limiting access to new treatments. #ATMI24 shows that only 43% of #ClinicalTrials took place in any #LMICs, despite these countries being home to nearly 80% of the global population. Read more➡️ tinyurl.com/mry2kb8p #Access2Meds
Working together is essential to creating global #HealthEquity. Coming tomorrow, the #HealthHeroes documentary highlights our impact on the ground & how joint action can drive lasting change. Learn more about our work➡️ accesstomedicinefoundation.org/achievements... #Access2Meds #GlobalHealth
With #GlobalHealth threats on the rise, the need to bridge access gaps is more urgent than ever. For over 20 years, the Foundation has guided #healthcare companies so that lifesaving products reach the people who need them most. Learn more➡️ accesstomedicinefoundation.org/healthcare-i... #Access2Meds
📣 Join our team in Amsterdam! We're looking for a Company Engagement Officer to manage relationships with #healthcare companies & engage industry stakeholders to drive change in #Access2Meds in #LMICs. Interested? Apply here➡️ accesstomedicinefoundation.org/company-enga... #vacancy #hiring #NGOJobs
The Health Equity #podcast is now on Spotify! Hosted by our CEO, @jayiyer.bsky.social, it features conversations with #healthcare leaders, innovators & changemakers. Together, they explore challenges & solutions for improving #Access2Meds in #LMICs. Listen here➡️ bit.ly/46VqriU #GlobalHealth
Limited health budgets & supply delays mean access to #diabetes care in Pacific island countries remains uncertain. How can #pharma, governments & partners address the unique access challenges in the region? Read more in our paper➡️ bit.ly/45GJBbW #insulin #Access2Meds #HealthEquity #GlobalHealth
In episode 5⃣ of The #HealthEquity podcast, @jayiyer.bsky.social speaks with Dr Boitumelo Semete-Makokotlela, CEO of SAHPRA, about the role of regulators as enablers of #Access2Meds in Africa & what's changing across the continent. Catch this & other episodes➡️ bit.ly/47DVz7s #GlobalHealth #podcast
How can #investors help expand #Access2Meds in #LMICs? In episode 3️⃣ of The Health Equity podcast, @jayiyer.bsky.social talks with PGGM’s Rogier Snijdewind about responsible investment as a catalyst for change in #GlobalHealth. Catch this & other episodes➡️ bit.ly/47DVz7s #GlobalHealth #podcast
✍️ Yeva Margaryan spoke with our CEO, @jayiyer.bsky.social, for CancerWorld magazine on the urgent need to close the gap in #CancerCare. The feature highlights the Foundation’s role in advancing #HealthEquity & holding #pharma companies accountable. Read more➡️ bit.ly/4oyygC2 #Access2Meds
In the latest episode of The #HealthEquity podcast, our CEO, @jayiyer.bsky.social, speaks with Florence Riako Anam, Co-Executive Director at @gnpplus.bsky.social, on how meaningful #patient engagement can lead to more equitable health systems. Listen now➡️ bit.ly/40Teirv #Access2Meds #GlobalHealth
This year, we launched The Health Equity #podcast 🎙️, a new platform to hear directly from the people working to close access gaps in #healthcare. Listen to the latest episodes, where we explore innovative solutions & share powerful stories of impact➡️ bit.ly/4lZW7Jo #Access2Meds #GlobalHealth
🎧 A new episode of The #HealthEquity podcast is out now!
@jayiyer.bsky.social speaks with Dr Boitumelo Semete-Makokotlela, CEO of SAHPRA, about the role of regulators as enablers of #Access2Meds in Africa & what's changing across the continent. Listen now➡️ bit.ly/4f2eH0v
We're pleased to announce the Expert Review Committee for the next iteration of Access to Medicine Index, including eight new members. The Committee will review & ratify the #ATMI26 methodology & provide strategic guidance. Learn more 👉 bit.ly/3IImCE6 #Access2Meds #GlobalHealth #HealthEquity
Despite carrying 25% of the global disease burden, Africa hosted just 1.1% of #ClinicalTrials in 2023. In her latest op-ed for @weforum.org, our CEO, @jayiyer.bsky.social, explains why expanding trials in Africa is critical for access & #GlobalHealth. Read more➡️ bit.ly/3GDv7zF #Access2Meds
The new episode of The #HealthEquity podcast is out now!🎙️Our CEO, @jayiyer.bsky.social, speaks with Andrea Lucard of @mmv.org on advancing inclusive innovation to strengthen access to #healthcare for women & girls, particularly in #LMICs. Listen here➡️ bit.ly/44mpIVx #Access2Meds #podcast
In the latest industry trend analysis, our Continuous Intelligence Unit reviews recent developments in #RSV preventive medicines for children, their potential to curb under-five mortality & what is needed to ensure they reach children who need them most➡️ bit.ly/4eirCet
#Access2Meds #HealthEquity
How can #investors help expand #Access2Meds in #LMICs? In the latest episode of The Health Equity podcast, @jayiyer.bsky.social talks with PGGM’s Rogier Snijdewind about responsible investment as a catalyst for change in #GlobalHealth.
Listen now➡️ bit.ly/4069Dlx
Looking forward to more events sponsored by drug companies about how we can all work together to improve access to their drugs 😩 #insulin4all #access2meds
Avanti Gupta, our Investor Engagement Manager, is speaking at #NordicSIF 2025 in Stockholm today, where she will share how our research helps #investors engage with #pharma on #Access2Meds & #GlobalHealth. Learn more➡️ bit.ly/452rVaN #ESG
The MPP Board met this week to shape our next 5⃣-year strategy alongside our team. We remain as committed as ever to ensuring innovative treatments and technologies reach those who need them most.
#GlobalHealth #InnovationForAll #PublicHealth #Access2Meds
Well said by @nickkristof.bsky.social on the unacceptable, unnecessary attack on existing Programmes for children. As an organization tracking progress in #access2meds globally the actions of the past days haunted us and also put decades of progress into jeopardy. @atmfoundation.bsky.social
Hello #Bluesky community!
I'm here to share and learn about #AMR, #StopSuperbugs, #access2meds, #GlobalHealth, #BizHumanRights, #HumanRights, and #ESG.
I really look forward to participating in fruitful and respectful conversations!
#NewJourney
🎙️On Saturday, Mila Maistat discussed access to #hepB and #hepC treatments in LMICs through MPP licences noting the crucial role of partnerships in the MPP model & the remarkable role of #India🇮🇳 in #Access2Meds worldwide 🌍🌐
📍 #IHS2025 #IndianHepatitisSummit2025 @worldhepalliance.bsky.social #NoHep
Sunday #insulin4all starter pack coming at you!
go.bsky.app/H28wMDi
If I forgot you, sorry and let me know! #diabetes #T1D #access2meds